New Study Shows ResistAid Selectively Enhances Immune Systems of Healthy Adults
The study was conducted in collaboration with Medicus Research LLC in Northridge, CA and published in the August issue of Nutrition Journal. Its findings confirm the ability of ResistAid to provide a selective response from the immune system.
Oct 1 2010 --- New research demonstrates the ability of ResistAid, Lonza’s all-natural arabinogalactan-based immune ingredient, to increase the antibody response of healthy volunteers to the 23-valent pneumococcal (pneumonia) vaccine. The study was conducted in collaboration with Medicus Research LLC in Northridge, CA and published in the August issue of Nutrition Journal. Its findings confirm the ability of ResistAid to provide a selective response from the immune system.
Vaccination studies of this type are used to study general immune function, with the vaccination being the immune system stressor. “The results of this randomized, double-blind, placebo-controlled, parallel group study demonstrate the ability of ResistAid to selectively enhance the antibody response to the pneumococcal vaccine,” said Dr. Jay Udani, MD, CPI, the Principal Investigator of the study and CEO of Medicus Research. ”Modulating the immune system in direct response to antigenic stimulation rather than nonspecific augmentation represents a more physiologic approach to immune enhancement.”
The study showed vaccinated volunteers who received ResistAid for 30 days prior to the vaccine and up till Day 72 demonstrated significantly higher pneumococcal IgG levels in two antibodies subtypes (18C and 23F) at both Day 51 and at Day 72 than the group that received placebo. These same subtypes (18C and 23F) also demonstrated statistically significant change scores from baseline in the ResistAid group at Day 51 and at Day 72.
“This study confirms Lonza’s ResistAid has the ability to provide a validated beneficial impact on the immune system in a healthy adult population,” said Bryan Rodriguez, Technical Marketing & Scientific Affairs Manager, Lonza. “In combination with its positive effects on the immune system, ResistAid has a number of technical properties that make it easily incorporated into dietary supplements and functional foods in standalone form or combined with other products to increase functionality.”
ResistAid is an all-natural immune health ingredient for food and dietary supplements. Boasting a potent combination of larch arabinogalactan and bioactive flavonoids, it provides both a humoral and cellular immune response. Benefiting from a patented, water-based extraction process from U.S. larch trees, ResistAid is manufactured according to HACCP. It is GMP-audited by the American Institute of Baking, is Kosher certified by the United Mehadrin and is GMO free. ResistAid has a monograph in the Food Chemicals Codex FCC.
To view the abstract of the study: http://www.ncbi.nlm.nih.gov/pubmed/20796315
